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S U M M A R Y
Corynebacterium jeikeium, frequently encountered in clinical specimens, is part of the normal skin ﬂora.
Nevertheless, a few cases of C. jeikeium bacteremia followed by severe clinical manifestations have been
reported. C. jeikeium has been reported to cause endocarditis, septicemia, meningitis, pneumonia and
osteomyelitis, along with soft tissue and trauma infections. Herein we describe a case of C. jeikeium
bacteremia in Greece. The isolation of a coryneform bacterium from a clinical specimen should not
immediately be considered a superinfection by the skin ﬂora. Clinical and laboratory investigations are
essential in order to evaluate such cases before applying appropriate treatment. On the other hand, the
association of coryneform bacteria and disease should be critically investigated, with a thorough
identiﬁcation of the strain, ideally beyond the classical methods, at a specialized center.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Corynebacterium jeikeium (C. jeikeium) is a Gram-positive,
aerobic bacterium commonly located on the surface of the skin,
constituting a part of the normal ﬂora and not causing disease.
However, in some rare cases, C. jeikeium bacteremia is responsible
for extremely severe clinical manifestations, which might result to
death, if left untreated. We describe a molecularly conﬁrmed case
of a C. jeikeium bacteremia in Greece.
2. Case report
A 67-year-old female patient, who had been undergoing
hemodialysis for the last two years, was admitted to the hospital
for a scheduled session, with a 2-day fever, fatigue, malaise and
weakness. A permanent, single lumen subclavian venous catheter
was being used for the hemodialysis; she also had a urinary
bladder catheter because of chronic interstitial cystitis (for the last
4months). During hemodialysis, the patient had a fever (39 8C) and
chills. Cultures of urine and blood (20 ml from one site (peripheral* Corresponding author. Tel.: +30 2310 206505; fax: +30 2310 968323.
E-mail address: ifathina@yahoo.gr (A.M. Ifantidou).
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doi:10.1016/j.ijid.2009.11.008vein) for an anaerobic and an aerobic bottle) were taken prior to
initiating antimicrobial therapy. Vancomycin (VAN; 1 g intrave-
nously once daily) plus amikacin (AMK; 500 mg intravenously
once daily) were initially started by the renal service (empirical
treatment). The patient was transferred to the internal medicine
department of the hospital. Upon transfer, intravenous levoﬂox-
acin (LEV; 500 mg every 12 h) was administered for the ﬁrst day,
followed by oral LEV (250 mg every 12 h) for the next 2 days. One
day after admission, the patient became afebrile. Hematological
investigations revealed a white blood cell count of 13.5  109/l, a
hemoglobin level of 12.7 g/dl, and a hematocrit of 38.3%. Urea was
elevated at 36.414mmol/l (reference range 3.570–17.850mmol/l),
while creatinine levels reached 486.2mmol/l (reference range 53–
97mmol/l). C-reactive protein was 55 mg/l. The urine culture and
anaerobic blood culture were negative, while a Gram-positive
coryneformbacteriumwas isolated from the aerobic blood culture.
This positive result was not disregarded as a contaminant.
On day 5 after admission, the patient developed another
feverish episode with the temperature reaching 38 8C, along with
rigors. Urine and blood cultures were collected during the
hemodialysis session (20 ml blood from the subclavian venous
catheter for an anaerobic and an aerobic bottle). The urine and
anaerobic blood cultures were both negative. The same Gram-
positive coryneform bacterium was isolated from the aerobicses. Published by Elsevier Ltd. All rights reserved.
Table 1
Biochemical characteristics and other traits of the isolated
bacterium
Biochemical characteristic/other trait Result
Fermentation/oxidation (F/O) O
Lipophilic +
Nitrate reduction 
Urease 
Esculin hydrolysis 
Acid production/glucose +
Acid production/sucrose 
Acid production/mannitol 
Acid production/xylose 
CAMP test 
Fructose 
Anaerobic growth 
Table 2
Antimicrobial susceptibility pattern of Corynebacterium jeikeium
Antimicrobial agent MIC (mg/l) S/R Breakpoint (mg/l)
Ampicillin (AMP) >32 R 1
Cefotaxime (CTX) >32 R 1
Chloramphenicol (CHL) 128 R 8
Ciproﬂoxacin (CIP) >32 R 1
Clindamycin (CLI) >256 R 0.5
Erythromycin (ERY) >256 R 0.5
Gentamicin (GEN) >256 R 1
Linezolid (LZD) 1 S 4
Moxiﬂoxacin (MXF) 16 R 1
Penicillin (PEN) >32 R 0.125
Rifampin (RIF) 0.016 S 1
Teicoplanin (TEC) 2 S 4
Tetracycline (TET) 16 R 1
Vancomycin (VAN) 2 S 4
S, sensitive; R, resistant.
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daily) simultaneously with rifampin (RIF; 600 mg orally every
12 h) for 3 weeks. One day after VAN administration, her
temperature again fell to within the normal range and the patient
has remained afebrile and in good clinical condition ever since. In a
scheduled hemodialysis session 3 weeks after the second feverish
episode, the urine and blood cultures (20 ml from one site
(peripheral vein) for an anaerobic and an aerobic bottle) were
negative.
Blood cultures were incubated in a Bactec 9050 analyzer
(Becton Dickinson, NJ USA). Positive blood cultures were inoculat-
ed onto Colombia agar plates (Becton Dickinson) supplemented
with 5% sheep blood (SBA). The plates were incubated at 37 8C in a
5% CO2 enriched atmosphere. Primary identiﬁcation of the two
strains, performed according to Gram stain and morphology of
colonies along with a set of biochemical properties, revealed C.
jeikeium (Table 1).1,2 After 24 h of growth, colonies were small
(0.5–1 mm), entire, low convex, grayish-white and non-hemolytic.
Gram stain revealed pleomorphic, occasionally club-shaped,
Gram-positive rods, arranged in V forms or palisades. The strains
were further characterized with the RapID CB plus system (Rymel)
as C. jeikeium.
DNA was extracted from cultured microorganisms using the
Qiagen DNA extraction kit (Qiagen, Hilden, Germany). A PCR that
ampliﬁes nearly the full-length of the 16S ribosomal DNA (rDNA)
using the primer set fD1–rP2 was applied, and a PCR product of
approximately 1500 bp was obtained.3 The strain was sent to a
specialized center (Dr Guido Funke, Department of Medical
Microbiology and Hygiene, Ga¨rtner & Colleagues Laboratories,
Weingarten, Germany), where the full 16S rDNA sequence
(>1400 bp) was established, conﬁrming that the microorganism
was C. jeikeium, being almost identical to C. jeikeium strain K411
(fully sequenced genome).
Although the isolated strain was multi-resistant to several
antibiotics, it was susceptible to glycopeptides (VAN, teicoplanin
(TEC)), linezolid (LZD) and RIF (Table 2). Molecular identiﬁcation
was conducted for both isolates and they were found to be
identical.
3. Discussion
Unusual cases of coryneform bacteria causing endocarditis
(Corynebacterium striatum,4 Corynebacterium amicolatum5) and
septicemia6 (Corynebacterium macginleyi), retrospectively, have
recently been reported. We have described a molecularly
conﬁrmed case of a C. jeikeium bacteremia in Greece.
Since positive results were obtained from both blood cultures
(from the peripheral vein and from the hemodialysis catheter), it
could not be determined if the infection was due to the presence of
the subclavian venous catheter (line infection). The catheter wasnecessary for hemodialysis, hence it was not removed. Therapeutic
application of the proper antibiotic scheme led to the successful
treatment of this C. jeikeium-induced bacteremia.
C. jeikeium is considered a bacterium of the normal skin ﬂora. It
is especially encountered in hospitalized patients, while it has also
been isolated from the broad hospital environment.7 C. jeikeium is
one of the most frequent Gram-positive coryneform bacteria
isolated from clinical specimens.2 The clinical spectrum of
manifestations attributed to C. jeikeium is wide. It has been
reported to cause endocarditis (particularly after surgical inter-
ventions), bacteremia, septicemia, meningitis, pneumonia, osteo-
myelitis or infectious arthritis after total hip arthroplasty
replacement plus skin, soft tissue, and trauma infections.8–13 A
case of endocarditis due to C. jeikeium in a Greek patient with acute
myelogenous leukemia has been described.14 In that case, the
result was based on two blood culture sets, along with a culture
taken from the skin lesion; however it was not conﬁrmed by
molecular methods. Furthermore, C. jeikeium-attributed sepsis
after administration of 8-methoxypsoralen for the treatment of a
cutaneous T-cell lymphoma has been reported.15 Several cases of
bacteremia caused by Corynebacterium spp in patients with central
venous catheters have been described. Colonization of the venous
catheter by Corynebacterium spp frequently co-exists with the
aforementioned bacteremia in such cases.16,17
C. jeikeium is resistant to a variety of antimicrobial agents.
Resistance is considered chromosome-mediated and not plasmid-
mediated.18 The bacterium is characteristically resistant to
penicillin, aminoglycosides and cephalosporins, it is sensitive to
glycopeptides and pristinamycin, while its sensitivity to erythro-
mycin, tetracycline, rifampin and to quinolones varies.7,9,19–25
Although C. jeikeium is a signiﬁcant opportunistic pathogen, its
presence in the hospital environment is probably the most
clinically important aspect of the natural history of this organism.
This is because there is recent evidence that drug resistance genes
may have transferred from corynebacteria to a Propionibacterium
sp clinical isolate. Thus, the high incidence of multiple drug-
resistant C. jeikeium suggests that this organism may be an
important environmental reservoir of drug resistance genes.26 C.
jeikeium is the most frequently recovered medically signiﬁcant
corynebacterial species in intensive care facilities.26
The evaluation of the clinical signiﬁcance of the isolation of a
Corynebacterium strain from clinical specimens is not always
easy. This is partly due to the fact that corynebacteria constitute
part of the normal skin ﬂora. Thus, their isolation might be
attributed to poor techniques during sample collection. In such
cases, there is not bacteremia, but the presence of the aforemen-
tioned bacterium in the skin. However, there are cases where
there is indeed bacteremia of coryneform bacteria and positive
Table 3
Indications that increase the clinical signiﬁcance of coryneform bacteria isolated from blood cultures—underlying diseases and risk factors
Underling disease Source
Neoplastic disease; immunosuppressed patients Wang et al. 2001,27 Van der Lelie et al. 1995,10 Ross et al. 2001,28
Mookadam et al. 200613
Cirrhosis Bhayani et al. 200932
Brain infarction; cerebrovascular disorders; subarachnoid hemorrhage;
spinal injury; multiple sclerosis
Otsuka et al. 200633
Diabetes Otsuka et al. 200633
Pneumonia Otsuka et al. 200633
Acute myocardial infarction Otsuka et al. 200633
Risk factors Source
Prosthetic material (catheters, cardiac valves, cerebrospinal ﬂuid shunt) Keren et al. 1988,29 Rozdzinski et al. 1991,30 Akan et al. 2002,31
Mookadam et al. 200613
Prolonged neutropenia Rozdzinski et al. 199130
Treatment with multiple antibiotics Rozdzinski et al. 199130
Extended hospitalization Umeh et al. 200415
Disruption of skin integuments; anal ﬁstula Brown 1995,34 Otsuka et al. 200633
Clinical and/or echocardiographic evidence of infective endocarditis Mookadam et al. 200613
Hemodialysis Mookadam et al. 200613
Adult male or postmenopausal female Van der Lelie et al. 199510
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positive cultures should be evaluated, according to speciﬁc
criteria. In these cases, further testing (more blood cultures
obtained, identiﬁcation to species level) and follow-up of the
patients are necessary. In particular, concomitant and underlying
diseases, along with various risk factors, increase the clinical
importance of coryneform bacteria isolated from blood cultures
(Table 3).1,10,13,27–34 Other indications of clinical signiﬁcance,
according to the experience of our center, include multiple blood
cultures positive for the same coryneform bacteria, absence of
isolation of other pathogenic microorganisms, symptoms and
signs compatible with bacteremia, and negative blood cultures or
recession of the febrile disease after applying appropriate
treatment according to the antibiogram. In the aforementioned
cases, the strains of the isolated coryneform bacteria should be
identiﬁed, combined with an antibiogram in order to determine
the proper treatment.
The clinical correlation between the isolation of C. jeikeium
strains and the feverish disease in our patient is based on the
following evidence: (1) The bacterium was isolated from a
normally sterile body site (blood); (2) the same bacterium was
isolated frommore than one specimen (subclavian venous catheter
and peripheral vein); (3) the identiﬁcation process revealed the
same microbial strain in both feverish episodes of the patient; (4)
no other pathogenic microorganism was isolated; (5) the
negativity of blood cultures and the ﬁnal recession of the febrile
disease were accomplished after initiating appropriate antimicro-
bial treatment, according to an antibiogram. Risk factors for a C.
jeikeium-related bacteremia in our patient were the presence of a
central venous catheter and the hemodialysis sessions, along with
her post-menopausal status.10,13
In conclusion, timely therapeutic intervention with the proper
antibiotic scheme can lead to the successful treatment of C.
jeikeium-induced bacteremia, without removal of the central
venous catheter.27 Isolation of a coryneform bacterium from a
clinical specimen has to be critically evaluated and followed by a
thorough identiﬁcation of the strain, ideally beyond the classical
methods, at a specialized center.
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